BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 16982872)

  • 1. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.
    Read S; Greenwald R; Izcue A; Robinson N; Mandelbrot D; Francisco L; Sharpe AH; Powrie F
    J Immunol; 2006 Oct; 177(7):4376-83. PubMed ID: 16982872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.
    Maker AV; Attia P; Rosenberg SA
    J Immunol; 2005 Dec; 175(11):7746-54. PubMed ID: 16301685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
    Coenen JJ; Koenen HJ; van Rijssen E; Boon L; Joosten I; Hilbrands LB
    J Immunol; 2006 May; 176(9):5240-6. PubMed ID: 16621989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
    Vasu C; Prabhakar BS; Holterman MJ
    J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.
    Wang Z; Davies JD
    Int Immunopharmacol; 2007 Feb; 7(2):249-65. PubMed ID: 17178393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.
    Zhu X; Yang P; Zhou H; Li B; Huang X; Meng Q; Wang L; Kijlstra A
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1549-57. PubMed ID: 17541623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
    Fecci PE; Ochiai H; Mitchell DA; Grossi PM; Sweeney AE; Archer GE; Cummings T; Allison JP; Bigner DD; Sampson JH
    Clin Cancer Res; 2007 Apr; 13(7):2158-67. PubMed ID: 17404100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.
    Li R; Perez N; Karumuthil-Melethil S; Prabhakar BS; Holterman MJ; Vasu C
    J Immunol; 2007 Oct; 179(8):5191-203. PubMed ID: 17911604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
    Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
    J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
    Takahashi T; Tagami T; Yamazaki S; Uede T; Shimizu J; Sakaguchi N; Mak TW; Sakaguchi S
    J Exp Med; 2000 Jul; 192(2):303-10. PubMed ID: 10899917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4.
    Wing JB; Ise W; Kurosaki T; Sakaguchi S
    Immunity; 2014 Dec; 41(6):1013-25. PubMed ID: 25526312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells.
    Totsuka T; Kanai T; Makita S; Fujii R; Nemoto Y; Oshima S; Okamoto R; Koyanagi A; Akiba H; Okumura K; Yagita H; Watanabe M
    Eur J Immunol; 2005 Jun; 35(6):1773-85. PubMed ID: 15902682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
    Taylor PA; Noelle RJ; Blazar BR
    J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
    Mandelbrot DA; McAdam AJ; Sharpe AH
    J Exp Med; 1999 Jan; 189(2):435-40. PubMed ID: 9892625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.